amifampridine has been researched along with Aura in 2 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wirtz, PW | 1 |
| Titulaer, MJ | 1 |
| Gerven, JM | 1 |
| Verschuuren, JJ | 1 |
| Albowitz, B | 1 |
| Kuhnt, U | 1 |
| Ehrenreich, L | 1 |
1 review available for amifampridine and Aura
| Article | Year |
|---|---|
3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Action Potentials; Amifampridine; Calcium Channels; Cholinergic Agents; Clinical Pr | 2010 |
1 other study available for amifampridine and Aura
| Article | Year |
|---|---|
Optical recording of epileptiform voltage changes in the neocortical slice.
Topics: 4-Aminopyridine; Amifampridine; Animals; Bicuculline; Cerebral Cortex; Convulsants; Electrophysiolog | 1990 |